Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
VP, Astellas Pharma
Ken has spent more than 20 years in the pharmaceutical industry at Astellas and most recent deals include Audentes in 2019 and Xyphos in 2020. Before becoming Head of Business Development in Astellas, he worked in Pharmacovigilance, International Regulatory Affairs Section and a Institute for Health Economics and Policy in Japan, where he studied the international regulatory environment surrounding our industry. Father of two sons, and a lifelong lover of Soccer.